{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T02:17:31Z","timestamp":1788401851917,"version":"build-2803163510"},"reference-count":22,"publisher":"Sociedade Portuguesa de Reumatologia","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ARP Rheumatol"],"DOI":"10.63032\/dgzn9101","type":"journal-article","created":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T15:20:27Z","timestamp":1725808827000},"page":"226-230","source":"Crossref","is-referenced-by-count":2,"title":["Ferric carboxymaltose-induced hypophosphatemia \u2013 a case series"],"prefix":"10.63032","volume":"3","member":"49459","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Kalantar-Zadeh K, Ganz T, Trumbo H, Seid MH, Goodnough LT, Levine MA. Parenteral iron therapy and phosphorus homeostasis: A review. Am J Hematol 2021;96(5):606-616. (In eng). DOI: 10.1002\/ajh.26100.","DOI":"10.1002\/ajh.26100"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Goretti Penido M, Alon US. Phosphate homeostasis and its role in bone health. Pediatr Nephrol 2012;27(11):2039-2048. (In eng). DOI: 10.1007\/s00467-012-2175-z.","DOI":"10.1007\/s00467-012-2175-z"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Amanzadeh J, Reilly RF, Jr. Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2006;2(3):136-48. (In eng). DOI: 10.1038\/ncpneph0124.","DOI":"10.1038\/ncpneph0124"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Glaspy JA, Lim-Watson MZ, Libre MA, et al. Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review. Ther Clin Risk Manag 2020;16:245-259. (In eng). DOI: 10.2147\/tcrm.S243462.","DOI":"10.2147\/TCRM.S243462"},{"key":"ref4","unstructured":"5. The global prevalence of anaemia in 2011. World Health Organization. September 2015. https:\/\/www.who.int\/publications\/i\/item\/9789241564960. Accessed in January 10th 2024."},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet 2021;397(10270):233-248. (In eng). DOI: 10.1016\/s0140-6736(20)32594-0.","DOI":"10.1016\/S0140-6736(20)32594-0"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. BLOOD MANAGEMENT: Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 2009;49(12):2719-2728. DOI: https:\/\/doi.org\/10.1111\/j.1537-2995.2009.02327.x.","DOI":"10.1111\/j.1537-2995.2009.02327.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Schaefer B, Tobiasch M, Wagner S, et al. Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management. Bone 2022;154:116202. (In eng). DOI: 10.1016\/j.bone.2021.116202.","DOI":"10.1016\/j.bone.2021.116202"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Rosano G, Schiefke I, G\u00f6hring UM, Fabien V, Bonassi S, Stein J. A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose. J Clin Med 2020;9(11) (In eng). DOI: 10.3390\/jcm9113587.","DOI":"10.3390\/jcm9113587"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Glaspy JA, Wolf M, Strauss WE. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome. Adv Ther 2021;38(7):3531-3549. (In eng). DOI: 10.1007\/s12325-021-01770-2.","DOI":"10.1007\/s12325-021-01770-2"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Schaefer B, Tobiasch M, Viveiros A, et al. Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis. Br J Clin Pharmacol 2021;87(5):2256-2273. (In eng). DOI: 10.1111\/bcp.14643.","DOI":"10.1111\/bcp.14643"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Wolf M, Rubin J, Achebe M, et al. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. Jama 2020;323(5):432-443. (In eng). DOI: 10.1001\/jama.2019.22450.","DOI":"10.1001\/jama.2019.22450"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Fragkos KC, Sehgal V, Rogers J, et al. Hypophosphataemia after intravenous iron therapy with ferric carboxymaltose-Real world experience from a tertiary centre in the UK. GastroHep 2020;2(5):205-214. DOI: https:\/\/doi.org\/10.1002\/ygh2.415.","DOI":"10.1002\/ygh2.415"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Vilaca T, Velmurugan N, Smith C, Abrahamsen B, Eastell R. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports. J Bone Miner Res 2022;37(6):1188-1199. (In eng). DOI: 10.1002\/jbmr.4558.","DOI":"10.1002\/jbmr.4558"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Urbina T, Belkhir R, Rossi G, et al. Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit. Journal of Bone and Mineral Research 2017;33(3):540-542. DOI: 10.1002\/jbmr.3369.","DOI":"10.1002\/jbmr.3369"},{"key":"ref15","unstructured":"16. Abridged List Ordered by Nutrient Content in Household Measure. United States Department of Agriculture. 2018. https:\/\/www.nal.usda.gov\/sites\/www.nal.usda.gov\/files\/phosphorus.pdf. Accssed in March 29th 2024."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Cundy T, Que L, Hassan IM, Hughes L. Bisphosphonate-Induced Deterioration of Osteomalacia in Undiagnosed Adult Fanconi Syndrome. JBMR Plus 2020;4(8):e10374. (In eng). DOI: 10.1002\/jbm4.10374.","DOI":"10.1002\/jbm4.10374"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Rosen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med 2003;348(15):1503-4. (In eng). DOI: 10.1056\/nejm200304103481521.","DOI":"10.1056\/NEJM200304103481521"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Collazo-Clavell ML, Jimenez A, Hodgson SF, Sarr MG. Osteomalacia after Roux-en-Y gastric bypass. Endocr Pract 2004;10(3):195-8. (In eng). DOI: 10.4158\/ep.10.3.195.","DOI":"10.4158\/EP.10.3.195"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Lin M, Ganda K. Treating 'osteoporosis': a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia. Endocrinol Diabetes Metab Case Rep 2022;2022 (In eng). DOI: 10.1530\/edm-22-0300.","DOI":"10.1530\/EDM-22-0300"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Boots JMM, Quax RAM. High-Dose Intravenous Iron with Either Ferric Carboxymaltose or Ferric Derisomaltose: A Benefit-Risk Assessment. Drug Saf 2022;45(10):1019-1036. (In eng). DOI: 10.1007\/s40264-022-01216-w.","DOI":"10.1007\/s40264-022-01216-w"},{"key":"ref21","unstructured":"22. Ferric carboxymaltose (Ferrinject) risk of symptomatic hypophosphatemia leading to osteomalacia and fractures. Medicines and Healthcare products Regulatory Agency. November 2020. https:\/\/www.gov.uk\/drug-safety-update\/ferric-carboxymaltose-ferinject-risk-of-symptomatic-hypophosphataemia-leading-to-osteomalacia-and-fractures. Accessed in January 10th 2024."}],"container-title":["ARP Rheumatology"],"original-title":[],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T20:33:12Z","timestamp":1728160392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.arprheumatology.com\/section.php?id=1709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,9,30]]}},"URL":"https:\/\/doi.org\/10.63032\/dgzn9101","relation":{},"ISSN":["2795-4552"],"issn-type":[{"value":"2795-4552","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}